参考来源: Emergent BioSolutions’ ACAM2000®, (smallpox and mpox (vaccinia) vaccine, live) receives US FDA approval for mpox indication; public health mpox outbreak continues across Africa & other regions. News release. Emergent ...
What is the ACAM2000 smallpox/mpox vaccine?ACAM2000 is a prescription vaccine that may be used to prevent smallpox and mpox disease in people of any age with a high chance of getting smallpox or mpox (previously called monkey pox)....
参考来源:‘Emergent BioSolutions’ ACAM2000, (smallpox and mpox (vaccinia) vaccine, live) receives US FDA approval for mpox indication; public health mpox outbreak continues across Africa & other regions. News release. Emergent BioSolutions. August 29, 2024. Accessed August 30, 2024.’温馨...
This study demonstrates the protective efficacy of multiple vaccine platforms against mpox virus challenge, including both current clinical vaccines and vectored subunit vaccines. Editor's summary: The global outbreak of mpox virus in 2022–2023 highlighted the need to ...
Differences in pathogenicity among the mpox virus clades: impact on drug discovery and vaccine development ACAM2000 • Second generation vaccine. • Live replicatingVACV. • Percutaneous administration with punctuated needle (one dose).
参考来源:‘ Emergent BioSolutions’ ACAM2000, (smallpox and mpox (vaccinia) vaccine, live) receives US FDA approval for mpox indication; public health mpox outbreak continues across Africa & other regions. News release. Emergent BioSolutions. August 29, 2024. Accessed August 30, 2024.’ ...
MpoxmonkeypoxACAMvaccinesafetydoi:10.1080/14760584.2023.2198600Basant E. KatameshView further author informationMaysa MadanyView further author informationFatma LabiebView further author informationAbdelaziz Abdelaaldrabdoseliem@gmail.comView further author information...
开发商 Emergent BioSolutions 在新闻稿中宣布,FDA 已批准一项补充生物制品许可申请,以扩大 ACAM2000 的适应症,包括预防感染风险高的个体的 mpox 疾病。 此前,该药的适应症仅限于预防天花。 此项批准得到了现有人类安全数据和动物研究的支持,这些研究证明了该疫苗对 mpox 病毒暴露的有效性。此前,Emergent 已向世...